Highland Ophthalmology Associates now offers Voyager™ Direct Selective Laser Trabeculoplasty (DSLT), an innovative advancement in glaucoma care. This new technology allows us to provide efficient and effective treatment for our patients with glaucoma and ocular hypertension.

Why We Are Offering Voyager™ DSLT

Voyager™ DSLT is a non-contact laser treatment designed to lower intraocular pressure. It offers several significant advantages over traditional methods:

• Exceptional Patient Comfort: The procedure is designed for a "gonio-free" experience, meaning no lens is placed on your eye during treatment.
• Rapid Treatment: The laser delivery itself is remarkably quick, lasting only 2.4 seconds.
• Fully Automated: The device uses advanced technology to track your natural eye movement, ensuring a precise and automated experience.
• Proven Results: Clinical trials demonstrated that DSLT provides effective eye pressure lowering that is sustained for 12 months after a single treatment.
• Reduced Dependency on Drops: Many patients find they can reduce their daily medication burden. In clinical studies, 70% of patients remained medication-free 12 months after their procedure.

What to Expect During Your Visit

If we determine that DSLT is right for you, the process is straightforward and efficient:

1. Preparation: You will receive standard eye drops.
2. Comfort: Your eye will be held open with a gentle lid speculum to help prevent blinking during the brief procedure.
3. Treatment: You will look at a fixed light while the device tracks your eye and completes the treatment in seconds.

Patient Satisfaction

Our patients' experiences are our top priority. Voyager™ DSLT has an extremely high patient satisfaction rate, with 96% satisfaction reported at six months. Additionally, 92.5% of patients indicated they would recommend this treatment to a friend with glaucoma.

Important Product Information

Indication: Voyager™ DSLT is indicated for use in selective laser trabeculoplasty (SLT) to treat patients with glaucoma or ocular hypertension.

Safety Profile: DSLT has an excellent safety profile. Short-term side effects may include mild discomfort, redness, blurry vision, or sensitivity to light. The most common side effect is a small, self-resolving red spot on the white part of the eye (punctate sub-conjunctival hemorrhage).

Contraindications: This treatment is not recommended for patients who cannot fixate their head or eyes, those with pupils that cannot constrict to 4 mm or less, or patients with certain glaucoma implants.

Is it time to upgrade your glaucoma treatment plan? Contact Highland Ophthalmology Associates today to schedule a consultation and see if Voyager™ DSLT is right for you.